Aperam is trading 4.4% down at €35.66, with no clear company-specific announcement directly explaining the move.
- Citi maintained its neutral rating and cut its price target from €50 to €42 on October 23; the report did not link the change to the decline.
- Broader markets were also under pressure on October 22, with S&P 500 and Nasdaq declines amid risk-off sentiment.
- Recent reporting cited persistent weakness in Aperam’s European demand outlook and expected lower Q3 EBITDA, but those updates predate the move.